DE69000960T2 - Zusammensetzung zur behandlung von pigmentierung. - Google Patents

Zusammensetzung zur behandlung von pigmentierung.

Info

Publication number
DE69000960T2
DE69000960T2 DE9090111782T DE69000960T DE69000960T2 DE 69000960 T2 DE69000960 T2 DE 69000960T2 DE 9090111782 T DE9090111782 T DE 9090111782T DE 69000960 T DE69000960 T DE 69000960T DE 69000960 T2 DE69000960 T2 DE 69000960T2
Authority
DE
Germany
Prior art keywords
spots
kojic acid
chloasma
composition
purified water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE9090111782T
Other languages
English (en)
Other versions
DE69000960D1 (de
Inventor
Yutaka Mishima
Masahiro Motono
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sansho Pharmaceutical Co Ltd
Original Assignee
Sansho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sansho Pharmaceutical Co Ltd filed Critical Sansho Pharmaceutical Co Ltd
Publication of DE69000960D1 publication Critical patent/DE69000960D1/de
Application granted granted Critical
Publication of DE69000960T2 publication Critical patent/DE69000960T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208—Tissues; Wipes; Patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)

Claims (1)

  1. Verwendung von Kojisäure zur Herstellung eines Arzneimittels zur Behandlung von endogener Chloasma, altersbedingter Flecken, Sonnenlicht-induzierter Flecken oder Pigmentflecken nach Entzündung.
DE9090111782T 1989-06-23 1990-06-21 Zusammensetzung zur behandlung von pigmentierung. Expired - Lifetime DE69000960T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP16115589 1989-06-23

Publications (2)

Publication Number Publication Date
DE69000960D1 DE69000960D1 (de) 1993-04-01
DE69000960T2 true DE69000960T2 (de) 1993-08-05

Family

ID=15729642

Family Applications (1)

Application Number Title Priority Date Filing Date
DE9090111782T Expired - Lifetime DE69000960T2 (de) 1989-06-23 1990-06-21 Zusammensetzung zur behandlung von pigmentierung.

Country Status (7)

Country Link
EP (1) EP0404162B1 (de)
JP (1) JP2977865B2 (de)
KR (1) KR0159917B1 (de)
AU (1) AU632585B2 (de)
CA (1) CA2018824C (de)
DE (1) DE69000960T2 (de)
HK (1) HK51694A (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69623504T2 (de) * 1996-11-04 2003-01-09 Childrens Hosp Medical Center Aufhellendes hautpflegemittel
CN1096845C (zh) * 1996-11-04 2002-12-25 普罗克特和甘保尔公司 皮肤增白组合物
ES2274618T3 (es) * 1998-02-06 2007-05-16 The Ester C Company Composiciones liquidas estables de ascorbato de calcio, y metodos de de preparacion y uso.
CA2420548A1 (en) * 2001-06-26 2003-01-09 Oxycal Laboratories, Inc. Composition comprising vitamin c and a pyrone or furanone compound
JP6502011B2 (ja) * 2013-10-07 2019-04-17 三省製薬株式会社 グルタチオン産生促進剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60202806A (ja) * 1984-03-26 1985-10-14 Sansho Seiyaku Kk 色白化粧料
JPS638310A (ja) * 1986-06-27 1988-01-14 Sansho Seiyaku Kk メラニン生成抑制外用薬剤
JPS63270619A (ja) * 1987-04-30 1988-11-08 Sansho Seiyaku Kk 外用剤
FR2616325B1 (fr) * 1987-06-12 1990-11-09 Moet Hennessy Rech Composition contenant de l'hydroquinone et de l'acide kojique et composition pharmaceutique, notamment dermatologique, a activite depigmentante ou anti-inflammatoire, ou cosmetique comprenant de l'acide kojique et de l'hydroquinone
JP2565513B2 (ja) * 1987-09-25 1996-12-18 三省製薬株式会社 メラニン生成抑制外用薬剤
JPS6483010A (en) * 1987-09-25 1989-03-28 Sansho Seiyaku Kk Melanization inhibitory drug for external use

Also Published As

Publication number Publication date
DE69000960D1 (de) 1993-04-01
JP2977865B2 (ja) 1999-11-15
KR0159917B1 (ko) 1998-12-01
AU5755190A (en) 1991-01-03
EP0404162B1 (de) 1993-02-24
CA2018824A1 (en) 1990-12-23
JPH0386821A (ja) 1991-04-11
KR910000144A (ko) 1991-01-29
EP0404162A1 (de) 1990-12-27
HK51694A (en) 1994-05-27
AU632585B2 (en) 1993-01-07
CA2018824C (en) 2001-09-11

Similar Documents

Publication Publication Date Title
DE69027057T2 (de) Retinal, dessen Derivate und deren therapeutische Verwendung
DE69827792T2 (de) Nichtirritierende kosmetische und pharmazeutische zusammensetzungen
DE3751761T2 (de) Penetrationsverbesserer für die transdermale Verabreichung von systemisch wirksamen Arzneimitteln
DE3832219A1 (de) Zusammensetzungen zur topischen anwendung mit melaninsynthese-inhibitoraktivitaet
EP1128812B1 (de) 5-aminolävulinsäure-nanoemulsion
DE3832218A1 (de) Zusammensetzungen zur topischen anwendung mit melaninsynthese-inhibitoraktivitaet
DE69534908T2 (de) Verwendung von statin zur behandlung von hauterkrankungen
DE1492438A1 (de) Eine duenne Schutzschicht bildendes kosmetisches Material
DE3111767A1 (de) Mittel zur behandlung der haut
EP0254869A2 (de) Verwendung von Aryloxycarbonsäure-Derivaten gegen dermatologische Erkrankungen
DE2707878C2 (de) Verwendung von Mono- und/oder Diglyceriden mittelkettiger Fettsäuren
DE69302396T2 (de) Antiviral wirksame pharmazeutische öl in wasser-emulsion, die 9-[(2-hydroxyethoxy)methyl]-guanin (acyclovir) oder ein salz oder einen ester davon enthält
EP0765663A2 (de) Verwendung von Dienogest zur Herstellung eines Arzneimittels zur Behandlung der Haut mittels topischer Anwendung
DE69005860T2 (de) Verwendung von 5'-Deoxy-5'-methylthioadenosin S-adenosylmethionin und dessen Salzen zur Herstellung von Seborrhea vermindernden Arzneimitteln.
DE69019151T2 (de) Salbe enthaltend Deprodone proprionate.
DE2601489A1 (de) Tretinoin enthaltende gelpraeparate
DE69305433T2 (de) Kosmetische oder dermatologische Zusammensetzung zur Hautdepigmentierung enthaltend eine di- oder tri-Kaffeoylchinasäure oder eine Mischung davon
EP1131063B1 (de) Hyperforin-salbe oder -creme
DE69000960T2 (de) Zusammensetzung zur behandlung von pigmentierung.
DE60035613T2 (de) Topische,kosmetische und pharmazeutische Mittel,enthaltend spezifische alkoxylierte Diester der Fumarsäure
DE2018599A1 (de) Aknemittel
DE60105617T2 (de) Zusammensetzung und insbesondere kosmetische Zusammensetzung , die DHEA und/oder einen Vorläufer oder ein Derivat von DHEA in Kombination mit mindestens einem Wirkstoff gegen Glykation enthält
EP1063998B1 (de) Medikament zur prophylaxe und/oder behandlung des mammarkarzinoms enthaltend einen steroidalen aromataseinhibitor
DE69727154T2 (de) Land- und meeressschildkrötenöle, diese enthaltende zusammensetzungen, verfahren zu deren herstellung und verwendungen
AT403434B (de) Topische zusammensetzung zur beschleunigung der wundheilung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition